Objective: Authors investigated, cross-nationally, the factors, including demographic, psychiatric (including cognitive), physical, and behavioral, determining whether older people take their prescribed medication. Older adults are prescribed more medication than any other group, and poor adherence is a common reason for nonresponse to medication. Methods: Researchers interviewed 3,881 people over age 65 who receive home care services in 11 countries, administering a structured interview in participants' homes. The main outcome measure was the percentage of participants not adherent to medication. Results: In all, 12.5% of people (N=456) reported that they were not fully adherent to medication. Non-adherence was predicted by problem drinking (OR=3.6), not having a doctor review their medication (OR=3.3), greater cognitive impairment (OR=1.4 for every one-point increase in impairment), good physical health (OR=1.2), resisting care (OR=2.1), being unmarried (OR=2.3), and living in the Czech Republic (OR=4.7) or Germany (OR=1.4). Conclusion: People who screen positive for problem drinking and who have dementia (often undiagnosed) are less likely to adhere to medication. Therefore, doctors should consider dementia and problem drinking when prescribing for older adults. Interventions to improve adherence in older adults might be more effective if targeted at these groups. It is possible that medication-review enhances adherence by improving the doctor-patient relationship or by emphasizing the need for medications.
Conversely, older adults may be more likely to adhere to medication because of, for example, lower rates of substance misuse. Some studies have excluded people with cognitive impairment and so may overestimate adherence in older people. Findings concerning the relationship of age with adherence have been inconsistent, finding, for example, improved adherence in people over 50,P 11 Pdecreased adherence in older age,P 12, 13 Pgreater adherence in patients age 55-64 than in older and younger groups,P 14 Pand, in people over 65, no difference in adherence between the younger and the oldest-old.P 10 PTrials of interventions to improve adherence so far have been disappointing.P
9,15
PKnowing more about the associates of non-adherence in older adults may help develop and target measures to increase the proportion of medication actually taken, and therefore potentially to improve their medication effectiveness.
Nearly 4,000 older adults, living in 11 countries, took part in the AdHOC (Aged in Home Care) Study. We used these data to carry out the first cross-national study of medication adherence and to investigate the relationship of putative risk factors to adherence.
METHODS
Ethics permission was granted in all countries according to local regulations.
Setting
A total of 3,881 adults (≥age 65 years, who were receiving health or social community services in any setting, participated in The AdHOC Study. Table 1 gives eligibility criteria for health and social services in the countries studied.P
16
PThe mean level of dependency of participants was lowest in the Nordic countries, the Netherlands, and the Czech Republic, followed by England and Germany, and highest in Italy and France.P
PItaly and the Czech Republic had the lowest levels of formal care provision, and the UK had the most. Table 2 describes the population, numbers interviewed, and refusal rates for each country. Each national study organizer selected an area judged to be representative of the country. Trained interviewers approached all potential participants in these areas for interview. Methodology has been described by The AdHOC Group.P
[ TABLE 1 ]

16
PWe included AdHOC study participants who were taking prescribed medication. Medication data were available for 3,803 people interviewed for the AdHOC study (98.0%), of whom 3,643 (95.8%) were taking prescribed medication.
[ TABLE 2 ]
Data Collection
We recorded patient information with the interRAI (www.interrai.org) Version 2.0 Minimum Data Set for Home Care (MDS-HC), which is a structured, standardized assessment instrument with adequate psychometric properties.P 17 PThe MDS-HC has been used for epidemiological research in several participating countries.P 16 PBefore data collection, the instrument was translated, back-translated, and examined for face validity in the language of each participating country. We used adherence as our main outcome measure, and divided it into three bands: 100%, ≥80%, and <80% adherence. We used this high cut-point for adherence because we expected high rates of nonadherence in this frail, elderly study population and because these thresholds have been used previously.P
18
PInterviewers asked the participant (or their caregiver, if the person was cognitively impaired or the caregiver administered the medication) open questions about their adherence such as "What medications have you taken today/yesterday?" to ascertain reported adherence over the last 7 days. They checked responses with medication available and with prescriptions. We also analyzed sociodemographic data, along with cognition, psychiatric, and physical health and medication details, which were collected at the interview.
Cognitive measure.
Cooper, C., Carpenter, I., Katona, C., Schroll, M., Wagner, C., Fialova, D., Livingstone, G. The ADHOC Study of older adults' adherences to medication in 11 countries. 
Behavioral symptoms.
Caregivers were asked about the presence of wandering (moving with no rational purpose, seemingly oblivious to needs or safety), verbally abusive behavior (threatening, screaming at, or cursing others), physically abusive behavior (hitting, shoving, scratching, sexually abusing others), socially inappropriate behavior (making disruptive sounds, noisiness, screaming, self-abusive acts, sexual behavior or disrobing in public, smearing or throwing food or feces, hoarding, rummaging through others' belongings), and resisting of care (resisting treatment, activities of daily living [ADL] assistance, eating, or changes in position) in the last 3 days, and each item was scored as 0 (behavior absent), 1 (behavior present but easily altered with current interventions), and 2 (present and not easily altered). This behavioral scale has been validated against the Alzheimer's Disease Patient Registry Physician Behavior checklist scores, with a correlation coefficient of 0.520. Over 2 years, the MDS behavior domain (Effect Size [ES]=0.058) was comparable to the Research Behavior Checklist (ES=0.065). These data demonstrate reasonable criterion validity of the MDS behavior rating scales.P 20 
Psychiatric morbidity.
Participants were asked whether they had a psychiatric or dementia diagnosis or had delirium in the last 7 days. We used the MDS-Depression Rating Scale Score (DRS), with a cut-off point of 2/3 for caseness. It has been validated against the Hamilton Rating Scale for Depression (Ham-D) and the Cornell Scale, a measure of depression in dementia (CSDD), and it has high sensitivity (94% and 78%, respectively) and specificity (72% and 77%, respectively)P
21
PIt compared favorably with the Geriatric Depression Scale (GDS) when tested against DSM-IV diagnosis.P 21 
Alcohol misuse.
Interviewees screened positive for alcohol misuse if, in the last 90 days, they had felt the need or were told to cut down on drinking, if others were concerned about their drinking, if they had a drink on waking to steady their nerves, or they had been in trouble because of drinking.
Physical functioning.
Physical functioning was measured by using the MDS Activities of Daily Living Hierarchy (MDS-ADL)P 
Medication.
Participants were asked about number of medications taken. Four classes of psychotropic drugs (antidepressants, anxiolytics, hypnotics, and antipsychotics) were coded as prescribed or not prescribed in the last 7 days. Participants were asked whether their medication had been reviewed by a doctor in the last 6 months.
Statistical Analysis
Because of the high number of statistical tests, we used a significance level of p <0.01 for univariate analyses. We calculated the proportion of people in the three categories of adherence and made crossnational comparisons using ANOVA and Tukey honestly significant difference (HSD) post-hoc tests to indicate which differences were significant. We determined which countries were significantly different from at least seven and at least eight others and reported this. We used χP 2 Ptests and univariate analyses of variance, as appropriate, to compare proportions and means of each variable studied. We used a logistic regression to determine which factors were independent predictors of non-adherence and calculated odds ratios (OR) and confidence intervals (CI). The independent variables we included were age; gender; country of residence; living alone; living with a caregiver; living in a Cooper, C., Carpenter, I., Katona, C., Schroll, M., Wagner, C., Fialova, D. , Livingstone, G. The ADHOC Study of older adults' adherences to medication in 11 countries. American Journal of Geriatric Psychiatry: 13, 2005, nr.12, p.1067-1076. -4-residential/nursing home; marital status; amount of formal and informal care received; scale scores for hearing, vision, wandering, resisting care, verbally or physically abusive or socially inappropriate behavior; score and caseness on CPS and DRS; screening positive for alcohol abuse; dementia diagnosis; any psychiatric diagnosis; ADL and IADL scale scores; number of medications; receipt of antidepressants, anxiolytics, antipsychotics, or hypnotics; occurrence of medication review in the last 6 months.
RESULTS
The overall response rate for people contacted was 79.7% (N=3,881).
Cross-National Variation
As shown in Table 3 , 12.5% of respondents overall (N=456) reported that they were not fully adherent to medication. The median number of medications prescribed was 6, and 82.4% of those interviewed (N=3,019) had received a medication review in the previous 6 months. Rates of nonadherence were highest in the Czech Republic and Germany.
[ TABLE 3 ]
Univariate Analysis Table 4 reports factors associated with reduced adherence on univariate analysis. Those who were not currently married, lived alone, were cases, or scored higher on the CPS or DRS scales, had been diagnosed with dementia or delirium, were cases on the alcohol screen, exhibited behavioral problems of resisting care or wandering, and who had not had their medication reviewed by a doctor in the last 6 months were all less likely to be adherent. Although people at all stages of dementia were less adherent than those without dementia, non-adherence rates demonstrated an inverted-U-shaped relationship with CPS score, with lowest adherence found in moderate dementia (Figure 1) . One-way ANOVA demonstrated that adherence rates varied significantly with CPS score (FB [6] B =7.32; p <0.001), Tukey HSD post-hoc tests indicated that the significant differences were between intact cognition and moderate (mean difference: 0.051; p <0.001) and moderately-severe (mean difference: 0.076; p <0.001) impairment.
[ TABLE 4 ] [ FIGURE 1 ]
Logistic Regression
As shown in Table 5 , non-adherence was predicted by screening positive for problem drinking, greater cognitive impairment, resisting care, being unmarried, lesser ADL impairment, having no medication review in the last 6 months, and living in the Czech Republic or Germany. The overall model had a -2B log P B Plikelihood of 766.250, cox and snell RP 
[ TABLE 5 ]
DISCUSSION
Reported adherence rates are higher than in previous studies and did not decline with age. This might be because earlier studies have examined discontinuation rates, whereas we measured adherence to established medication regimes. Most older adults interviewed adhered to medication, even when experiencing psychiatric illness, physical morbidity, or cognitive decline, and despite taking, on average, six different types of medication daily. Problem drinking, dementia, having no medication review in the last 6 months, resisting care, and poorer ADL functioning predicted non-adherence. Cooper, C., Carpenter, I., Katona, C., Schroll, M., Wagner, C., Fialova, D. , Livingstone, G. The ADHOC Study of older adults' adherences to medication in 11 countries. American Journal of Geriatric Psychiatry: 13, 2005, nr.12, p.1067-1076. -5-Decreased adherence was associated with dementia and with resisting care, which often occurs in people who have limited insight into their dementia. The non-linear relationship between adherence to medication and cognitive functioning, with adherence lowest in those with moderate impairment, appears to explain previous conflicting research findings. Perhaps participants with mild cognitive impairments are more aware of their impairment and use systems such as pillboxes to help remind them to take their medication. This would suggest that practitioners could improve treatment adherence by tailoring interventions to the degree of cognitive impairment. More people with severe dementia live with others who act as caregivers, prompting or administering their medication, because of their greater care needs. This could explain their increased adherence compared with people with moderate dementia, who are more likely to live alone. Results suggest that those who live alone with significant cognitive impairment are most likely to be non-adherent. Non-adherence could be a significant factor determining when institutionalization is required.
Country of Residence
Living in Germany or the Czech Republic predicted non-adherence. In the Czech Republic, this might relate to the lower levels of formal service provision, either because medication was monitored less often or because good relationships between the carerecipient and provider could foster good adherence. This cannot be the only factor influencing results, however, because Germany had similar levels of service provision to other countries, but lower adherence.
Measurement biases between raters from different countries could have accounted for part of the association of adherence with country of residence, but there may also be true national differences, over and above confounding factors, in the likelihood of people adhering to medication. In the Czech Republic, the older people might have felt less able to approach doctors to discuss medication problems because of their experiences during the communist era of doctors as strong hierarchical figures. Medical staff in the Czech Republic have particularly high caseloads and are perhaps less accustomed to asking patients about adherence. Many older Czech people are economically disadvantaged, but they are subject to the same prescription charges as younger adults. For economic reasons, older drugs, which are less effective and have more side effects, are more likely to be used there than in Western Europe.P 24 We did not study the association of non-adherence with the cost of medication, but people pay more for their medication in Germany, on average, than in the other countries studied,P
25
Pand it is possible that this could account for the higher rates of non-adherence in that country. This is consistent with research in the United States, finding that many elderly persons, most of whom pay for their own medication, are unable to afford to fill their prescriptions.P
26
Possible Interventions
Review of medication by a doctor in the last 6 months was associated with improved adherence. Attending for regular medication review might reflect an obedient, medicalized individual who is also more compliant with medication. It is also possible that a medication review enhances adherence by improving the doctor-patient relationship or by emphasizing the relevance of medications. Polypharmacy is common in older people,P
27
Pand it has been suggested that reviewing and possibly reducing the number of medications might help adherence.P 28 PHowever, number of medications was not a significant predictor of nonadherence in our study. This may be explained by the "intent-to-treat" effect of doctors prescribing more medications to patients they judge more likely to take them. Our results suggest that treatment of problem drinking and dementia might also improve adherence. This presents a difficulty, because effective treatment programs often include medication.
Currently, the evidence for interventions specifically developed to improve adherence is not convincing.P
9,15
PWe suggest that the failure of studies in this area to differentiate between people with and without cognitive impairment may have limited the effectiveness of the interventions. Perhaps simpler interventions are useful where cognitive deficits are present, but in unimpaired older people, as has been suggestedP 
Study Strengths and Limitations
This is the largest-ever study of medication adherence. We compared rates of adherence crossnationally, investigated most postulated associations for non-adherence, and considered whether they Cooper, C., Carpenter, I., Katona, C., Schroll, M., Wagner, C., Fialova, D. , Livingstone, G. The ADHOC Study of older adults' adherences to medication in 11 countries. American Journal of Geriatric Psychiatry: 13, 2005, nr.12, p.1067-1076. -6-are independent predictors. To collect adherence data, we combined subjective and objective measurements of adherence. This method had good face validity and does not change behavior, unlike, for example, electronic pillboxes, although self-report measures have been found to significantly overestimate adherence rates.P 30 PWe did not have data about use of reminder systems such as pillboxes. The sample consisted of those who had home-care services and was, therefore, not random. It is likely that people who refuse services are the least adherent group, and they were not sampled. There were higher refusal rates in Finland, Sweden, the Netherlands, and UK. Those who refused to be interviewed may have been less adherent, so overall adherence may have been over-estimated. Caregivers were asked about non-adherence where they were responsible for administering the medication, but they may have been reluctant to report non-adherence if they perceived tablet intake as their responsibility. Therefore, although the adherence in the dementia group was poor, it might still have been an overestimate.
CONCLUSION
Doctors may increase adherence in older people by reviewing medication every 6 months and by considering dementia when prescribing. Improved detection of dementia and alcohol use disorders might have a positive impact on adherence. Interventions developed to improve adherence might be more effective if adapted for and targeted at specific populations, for example people with moderate cognitive impairment. Cooper, C., Carpenter, I., Katona, C., Schroll, M., Wagner, C., Fialova, D. , Livingstone, G. The ADHOC Study of older adults' adherences to medication in 11 countries. American Journal of Geriatric Psychiatry: 13, 2005, nr.12, p.1067-1076. 
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